BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 21, 2025
Home » Authors » Omar Ford

Articles by Omar Ford

J&J Earnings Report: J&J struggles with sluggish device revenue in 2Q15

July 16, 2015
By Omar Ford

New Trade Association: Association forms to help smaller device firms promote value-based solutions

July 15, 2015
By Omar Ford

Looking to Avoid Neverland: Medtronic says no to 'never events', buys RF Surgical Systems for $235 million

July 14, 2015
By Omar Ford
Medtronic (NYSE:MDT) (Dublin) could penetrate a new market with its planned acquisition of RF Surgical Systems (Carlsbad Calif.), a private company that is focused on the detection and prevention of retained surgical items and reducing "never events" in hospital settings.
Read More

Push to bring Flexivue to Market: Presbia passes enrollment halfway mark for second stage of pivotal study

July 10, 2015
By Omar Ford

First patient enrolled in study: Intersect ENT goes Nova in pivotal study for sinus implant

July 9, 2015
By Omar Ford

Odd Duckling Turning into Swan: Proteus is 'odd' but 'attractive' duck in emerging digital healthcare market

July 8, 2015
By Omar Ford
Just because it looks like a duck and quacks like a duck, doesn't always mean it's a duck. Take Proteus Digital Health (Redwood City, Calif.) for example. While the company has developed and received 510(k) clearances for a device that can aid in the measurement of medication adherence, the privately owned firm said that it doesn't necessarily consider itself to be a med-tech firm.
Read More

MDD's Cardiology Extra

July 7, 2015
By Omar Ford

Hansen gets bump to start ARTISAN: Hansen Medical completes enrollment in initial cohort of ARTISAN clinical trial

July 7, 2015
By Omar Ford
Coming off a 5.07% bump in its shares last week, intravascular robotics specialist Hansen Medical (NASDAQ: HNSN) (Mountain View, Calif.) said it has completed enrollment in the initial evaluable cohort of its ARTISAN clinical trial.
Read More

Stryker seeks Lucky Strike: Medsurg unit goes for acquisitions,OUS presence to gain market share

July 6, 2015
By Omar Ford

MDD Interview: Med-tech veteran delves into regenerative meds with Mimedix

July 2, 2015
By Omar Ford
Previous 1 2 … 54 55 56 57 58 59 60 61 62 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing